Black Rock Inc. Sarepta Therapeutics, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
501Shares Held
89.2MCall Options Held
1.39MPut Options Held
1.13M-
Capital International Investors Los Angeles, CA9.06MShares$121 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$120 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$54.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$44.8 Million0.12% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.67MShares$35.6 Million2.76% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.17B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...